Usefulness of Iron Deficiency Correction in Management of Patients With Heart Failure [from the Registry Analysis of Iron Deficiency-Heart Failure (RAID-HF) Registry]

American Journal of Cardiology

Volumn 118, Issue 12, 2016, Pages 1875-1880

  Wienbergen, Harm ^a   Pfister, Otmar ^b   Hochadel, Matthias ^c   Michel, Stephan ^a   Bruder, Oliver ^d   Remppis, Björn Andrew ^e   Maeder, Micha Tobias ^f   Strasser, Ruth ^g   von Scheidt, Wolfgang ^h   Pauschinger, Matthias ⁱ   Senges, Jochen ^c   Hambrecht, Rainer ^a  

^a Bremer Institut für Herz und Kreislaufforschung Am Klinikum Links der Weser   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Foundation Stiftung Institut für Herzinfarktforschung   (Germany)

^d ELISABETH KRANKENHAUS ESSEN   (Germany)

^e Division of Cardiology   (Germany)

^f CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^g DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^h KLINIKUM AUGSBURG   (Germany)

ⁱ KLINIKUM NÜRNBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN; IRON; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FERRIC ION; MALTOSE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TRACE ELEMENT;

AGED; ANEMIA; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GERMANY; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL READMISSION; HUMAN; IRON DEFICIENCY; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; SWITZERLAND; SYMPTOM; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; ANEMIA, IRON-DEFICIENCY; BLOOD; COMPLICATION; DISEASE MANAGEMENT; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; REGISTER; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; C-REACTIVE PROTEIN; COHORT STUDIES; DISEASE MANAGEMENT; FEMALE; FERRIC COMPOUNDS; GERMANY; HEART FAILURE; HUMANS; IRON; LOGISTIC MODELS; MALE; MALTOSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PEPTIDE FRAGMENTS; PREVALENCE; REGISTRIES; SWITZERLAND; TRACE ELEMENTS; TREATMENT OUTCOME;

EID: 84998773681     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.08.081     Document Type: Article

References (29)

1. 1 von Scheidt, W., Zugck, C., Pauschinger, M., Hambrecht, R., Bruder, O., Hartmann, A., Rauchhaus, M., Zahn, R., Brachmann, J., Tebbe, U., Neumann, T., Strasser, R.H., Boehm, M., Stork, S., Hochadel, M., Heidemann, P., Senges, J., Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol 103 (2014), 1006–1014.
2. 2 World Health Organization. Worldwide prevalence of anaemia 1995-2005. WHO global database on anaemia. Available at: http://www.who.int. Assessed on June 23, 2016.
3. 3 Levey, A.S., Coresh, J., Balk, E., Kausz, A.T., Levin, A., Steffes, M.W., Hogg, R.J., Perrone, R.D., Lau, J., Eknoyan, G., National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003), 137–147.
4. 4 Greiner, W., Claes, C., Busschbach, J.J., von der Schulenburg, J.M., Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 6 (2005), 124–130.
5. 5 Jankowska, E.A., von Haehling, S., Anker, S.D., Macdougall, I.C., Ponikowski, P., Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 34 (2013), 816–829.
6. 6 van Veldhuisen, D.J., Anker, S.D., Ponikowski, P., Macdougall, I.C., Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol 8 (2011), 485–493.
7. 7 Macdougall, I.C., Canaud, B., de Francisco, A.L., Filippatos, G., Ponikowski, P., Silverberg, D., van Veldhuisen, D.J., Anker, S.D., Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency. Eur J Heart Fail 14 (2012), 882–886.
8. 8 Andrews, N.C., Disorders of iron metabolism. N Engl J Med 341 (1999), 1986–1995.
9. 9 Jankowska, E.A., Rozentryt, P., Witkowska, A., Nowak, J., Hartmann, O., Ponikowska, B., Borodulin-Nadzieja, L., Banasiak, W., Polonski, L., Filippatos, G., McMurray, J.J., Anker, S.D., Ponikowski, P., Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 31 (2010), 1872–1880.
10. 10 Jankowska, E.A., Rozentryt, P., Witkowska, A., Nowak, J., Hartmann, O., Ponikowska, B., Borodulin-Nadzieja, L., von Haehling, S., Doehner, W., Banasiak, W., Polonski, L., Filippatos, G., Anker, S.D., Ponikowski, P., Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail 17 (2011), 899–906.
11. 11 Enjuanes, C., Klip, I.T., Bruguera, J., Cladellas, M., Ponikowski, P., Banasiak, W., van Veldhuisen, D.J., van der Meer, P., Jankowska, E.A., Comin-Colet, J., Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study. Int J Cardiol 174 (2014), 268–275.
12. 12 Okonko, D.O., Mandal, A.K., Missouris, C.G., Poole-Wilson, P.A., Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol 58 (2011), 1241–1251.
13. 13 Jankowska, E.A., Kasztura, M., Sokolski, M., Bronisz, M., Nawrocka, S., Oleskowska-Florek, W., Zymlinski, R., Biegus, J., Siwolowski, P., Banasiak, W., Anker, S.D., Filippatos, G., Cleland, J.G., Ponikowski, P., Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. Eur Heart J 35 (2014), 2468–2476.
14. 14 Hasenfuß, G., Anker, S., Bauersachs, J., Böhm, M., Hoppe, U.C., Pieske, B., von Scheidt, W., Wachter, R., Kommentar zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Behandlung der akuten und chronischen Herzinsuffizienz. Kardiologe 7 (2013), 105–114.
15. 15 McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchio, A., Boehm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., Gomez-Sanchez, M.A., Jaarsma, T., Kober, L., Lip, G.Y., Maggioni, A.P., Parkhomenko, A., Pieske, B.M., Popescu, B.A., Ronnevik, P.K., Rutten, F.H., Schwitter, J., Seferovic, P., Stepinska, J., Trindade, P.T., Voors, A.A., Zannad, F., Zeiher, A., ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur Heart J 33 (2012), 1787–1847.
16. 16 Ponikowski, P., Voors, A.A., Anker, S.D., Bueno, H., Cleland, J.G., Coats, A.J., Falk, V., Gonzalez-Juanatey, J.R., Harjola, V.P., Jankowska, E.A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J.T., Pieske, B., Riley, J.P., Rosano, G.M., Ruilope, L.M., Ruschitzka, F., Rutten, F.H., van der Meer, P., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 37 (2016), 2129–2200.
17. 17 Silverberg, D.S., Schwartz, D., Schwartz, I., Ben Assa, E., The missed opportunities to diagnose and treat iron deficiency in patients hospitalized with heart failure. Int J Cardiol 168 (2013), 2164–2166.
18. 18 Cohen-Solal, A., Damy, T., Terbah, M., Kerebel, S., Baquet, J.P., Hanon, O., Zannad, F., Laperche, T., Leclercq, C., Concas, V., Duvillié, L., Darné, B., Anker, S., Mebazaa, A., High prevalence of iron deficiency in patients with acute decompensated heart failure. Eur J Heart Fail 16 (2014), 984–991.
19. 19 Parikh, A., Natarajan, S., Lipsitz, S.R., Katz, S.D., Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: prevalence and associations with anemia and inflammation. Circ Heart Fail 4 (2011), 599–606.
20. 20 Klip, I.T., Comin-Colet, J., Voors, A.A., Ponikowski, P., Enjuanes, C., Banasiak, W., Lok, D.J., Rosentryt, P., Torrens, A., Polonski, L., van Veldhuisen, D.J., van der Meer, P., Jankowska, E.A., Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 165 (2013), 575–582.
21. 21 Okonko, D.O., Grzeslo, A., Witkowski, T., Mandal, A.K., Slater, R.M., Roughton, M., Foldes, G., Thum, T., Majda, J., Banasiak, W., Missouris, C.G., Poole-Wilson, P.A., Anker, S.D., Ponikowski, P., Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 51 (2008), 103–112.
22. 22 Anker, S.D., Colet, J.C., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Luscher, T.F., Mori, C., von Eisenhart Rothe, B., Pocock, S., Poole-Wilson, P.A., Ponikowski, P., Rationale and design of Ferinject assessment in patients with iron deficiency and chronic heart failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. Eur J Heart Fail 11 (2009), 1084–1091.
23. 23 Anker, S.D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Luscher, T.F., Bart, B., Banasiak, W., Niegowska, J., Kirwan, B.A., Mori, C., von Eisenhart Rothe, B., Pocock, S.J., Poole-Wilson, P.A., Ponikowski, P., Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361 (2009), 2436–2448.
24. 24 Ponikowski, P., van Veldhuisen, D.J., Comin-Colet, J., Ertl, G., Komajda, M., Mareev, V., McDonagh, T., Parkhomenko, A., Tavazzi, L., Levesque, V., Mori, C., Roubert, B., Filippatos, G., Ruschitzka, F., Anker, S.D., Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J 36 (2015), 657–668.
25. 25 Avni, T., Leibovici, L., Gafter-Gvili, A., Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail 14 (2012), 423–429.
26. 26 Kapoor, M., Schleinitz, M.D., Gemignani, A., Wu, W.C., Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis. Cardiovasc Hematol Disord Drug Targets 13 (2013), 35–44.
27. 27 Jankowska, E.A., Tkaczyszyn, M., Suchocki, T., Drozd, M., von Haehling, S., Doehner, W., Banasiak, W., Filippatos, G., Anker, S.D., Ponikowski, P., Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail 18 (2016), 786–795.
28. 28 Keating, G.M., Ferric carboxymaltose: a review of its use in iron deficiency. Drugs 75 (2015), 101–127.
29. 29 Gutzwiller, F.S., Schwenkglenks, M., Blank, P.R., Braunhofer, P.G., Mori, C., Szucs, T.D., Ponikowski, P., Anker, S.D., Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK. Eur J Heart Fail 14 (2012), 782–790.